Latest Articles

Publication Date
All News Scientific
'Left in Limbo’: Donegal women forced abroad for endometriosis care - Ireland Live

'Left in Limbo’: Donegal women forced abroad for endometriosis care Ireland Live

Published: March 23, 2025, 4:38 p.m.
Read Full Article
'Left in Limbo’: Donegal women forced abroad for endometriosis care - Donegal Live

'Left in Limbo’: Donegal women forced abroad for endometriosis care Donegal Live

Published: March 23, 2025, 4 p.m.
Read Full Article
Trips taking kids harmed by Chernobyl to Nottingham forced to end - Yahoo News UK

Trips taking kids harmed by Chernobyl to Nottingham forced to end Yahoo News UK

Published: March 20, 2025, 6:58 p.m.
Read Full Article
Endometrial Ablation Market Size to Hit USD 2.15 Bn by 2034 - Precedence Research

Endometrial Ablation Market Size to Hit USD 2.15 Bn by 2034 Precedence Research

Published: March 20, 2025, 1:41 p.m.
Read Full Article
All layers of North West health service need to be adequately resourced - MacLochlainn - Ocean FM

All layers of North West health service need to be adequately resourced - MacLochlainn Ocean FM

Published: March 20, 2025, 9:40 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - The Malaysian Reserve

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy The Malaysian …

Published: March 19, 2025, 10:53 p.m.
Read Full Article
Canada Approves KEYTRUDA For Advanced Endometrial Cancer - Evrim Ağacı

Canada Approves KEYTRUDA For Advanced Endometrial Cancer Evrim Ağacı

Published: March 19, 2025, 2:55 p.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Weekly Voice

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Weekly Voice

Published: March 19, 2025, 11:20 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Canada Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Canada …

Published: March 19, 2025, 11 a.m.
Read Full Article
Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy - Yahoo Finance

Health Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as Monotherapy Yahoo Finance

Published: March 19, 2025, 11 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!